Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.06)
# 1,281
Out of 4,778 analysts
587
Total ratings
40.31%
Success rate
0.31%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LQDA Liquidia | Reiterates: Buy | $29 | $15.60 | +85.90% | 12 | Mar 20, 2025 | |
| STOK Stoke Therapeutics | Reiterates: Buy | $47 | $7.76 | +505.67% | 13 | Mar 19, 2025 | |
| RNA Avidity Biosciences | Reiterates: Buy | $72 | $32.12 | +124.16% | 4 | Mar 18, 2025 | |
| DYN Dyne Therapeutics | Reiterates: Buy | $46 | $11.41 | +303.33% | 11 | Mar 17, 2025 | |
| STRO Sutro Biopharma | Downgrades: Neutral | $12 → $2 | $0.76 | +161.99% | 16 | Mar 17, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.87 | +436.19% | 17 | Mar 17, 2025 | |
| VIGL Vigil Neuroscience | Maintains: Buy | $17 → $14 | $1.77 | +693.20% | 13 | Mar 14, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $20 | $12.50 | +60.00% | 14 | Mar 14, 2025 | |
| ACIU AC Immune | Reiterates: Buy | $16 | $1.98 | +708.08% | 14 | Mar 14, 2025 | |
| ARVN Arvinas | Reiterates: Buy | $81 | $8.13 | +896.31% | 17 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.61 | +645.34% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $3.98 | +226.63% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.09 | +55.15% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.73 | +386.26% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.45 | +938.06% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.75 | +190.91% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $3.78 | +217.88% | 19 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $9.44 | +133.05% | 11 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $46.96 | +81.01% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $25.72 | +36.11% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $60 | $31.80 | +88.68% | 7 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $87 | $14.14 | +515.28% | 21 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $17.11 | +57.80% | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $425 | $316.57 | +34.25% | 14 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.30 | +440.54% | 9 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $40 | $11.29 | +254.30% | 13 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $3.12 | +28.41% | 17 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.07 | +271.75% | 9 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.51 | +959.60% | 11 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $12.67 | +278.85% | 16 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $185 | $116.14 | +59.30% | 19 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $78.56 | +14.56% | 13 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $6.10 | +1,129.51% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $93.15 | +44.93% | 17 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $241 | $139.18 | +73.16% | 19 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $550 | $508.99 | +8.06% | 26 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $27.27 | +39.35% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $27.54 | +172.33% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $20.28 | +294.48% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.48 | +1,109.68% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.87 | +819.22% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $6 | $2.77 | +117.00% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.19 | +1,165.82% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $35 | $4.12 | +749.51% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.27 | +529.92% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.17 | +222.58% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.88 | +45.35% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.35 | +1,602.13% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.59 | +25,323.73% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $0.45 | +562.98% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $6.68 | +124.55% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $2.18 | +1,734.86% | 3 | Mar 16, 2022 |
Liquidia
Mar 20, 2025
Reiterates: Buy
Price Target: $29
Current: $15.60
Upside: +85.90%
Stoke Therapeutics
Mar 19, 2025
Reiterates: Buy
Price Target: $47
Current: $7.76
Upside: +505.67%
Avidity Biosciences
Mar 18, 2025
Reiterates: Buy
Price Target: $72
Current: $32.12
Upside: +124.16%
Dyne Therapeutics
Mar 17, 2025
Reiterates: Buy
Price Target: $46
Current: $11.41
Upside: +303.33%
Sutro Biopharma
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.76
Upside: +161.99%
Zentalis Pharmaceuticals
Mar 17, 2025
Reiterates: Buy
Price Target: $10
Current: $1.87
Upside: +436.19%
Vigil Neuroscience
Mar 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.77
Upside: +693.20%
KalVista Pharmaceuticals
Mar 14, 2025
Reiterates: Buy
Price Target: $20
Current: $12.50
Upside: +60.00%
AC Immune
Mar 14, 2025
Reiterates: Buy
Price Target: $16
Current: $1.98
Upside: +708.08%
Arvinas
Mar 14, 2025
Reiterates: Buy
Price Target: $81
Current: $8.13
Upside: +896.31%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.61
Upside: +645.34%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $3.98
Upside: +226.63%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.09
Upside: +55.15%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $4.73
Upside: +386.26%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.45
Upside: +938.06%
Mar 6, 2025
Initiates: Buy
Price Target: $8
Current: $2.75
Upside: +190.91%
Mar 5, 2025
Reiterates: Buy
Price Target: $12
Current: $3.78
Upside: +217.88%
Mar 5, 2025
Reiterates: Buy
Price Target: $22
Current: $9.44
Upside: +133.05%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $46.96
Upside: +81.01%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $25.72
Upside: +36.11%
Feb 28, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $31.80
Upside: +88.68%
Feb 28, 2025
Maintains: Buy
Price Target: $80 → $87
Current: $14.14
Upside: +515.28%
Feb 27, 2025
Reiterates: Buy
Price Target: $27
Current: $17.11
Upside: +57.80%
Feb 27, 2025
Reiterates: Buy
Price Target: $425
Current: $316.57
Upside: +34.25%
Feb 27, 2025
Reiterates: Buy
Price Target: $7
Current: $1.30
Upside: +440.54%
Feb 27, 2025
Maintains: Buy
Price Target: $47 → $40
Current: $11.29
Upside: +254.30%
Feb 26, 2025
Reiterates: Neutral
Price Target: $4
Current: $3.12
Upside: +28.41%
Feb 25, 2025
Reiterates: Buy
Price Target: $30
Current: $8.07
Upside: +271.75%
Feb 24, 2025
Reiterates: Buy
Price Target: $16
Current: $1.51
Upside: +959.60%
Feb 24, 2025
Reiterates: Buy
Price Target: $48
Current: $12.67
Upside: +278.85%
Feb 24, 2025
Reiterates: Buy
Price Target: $185
Current: $116.14
Upside: +59.30%
Feb 24, 2025
Reiterates: Buy
Price Target: $90
Current: $78.56
Upside: +14.56%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $6.10
Upside: +1,129.51%
Feb 14, 2025
Reiterates: Buy
Price Target: $135
Current: $93.15
Upside: +44.93%
Feb 13, 2025
Maintains: Buy
Price Target: $300 → $241
Current: $139.18
Upside: +73.16%
Feb 11, 2025
Reiterates: Buy
Price Target: $550
Current: $508.99
Upside: +8.06%
Feb 11, 2025
Reiterates: Buy
Price Target: $38
Current: $27.27
Upside: +39.35%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $27.54
Upside: +172.33%
Dec 20, 2024
Reiterates: Buy
Price Target: $80
Current: $20.28
Upside: +294.48%
Dec 17, 2024
Reiterates: Buy
Price Target: $30
Current: $2.48
Upside: +1,109.68%
Nov 15, 2024
Reiterates: Buy
Price Target: $8
Current: $0.87
Upside: +819.22%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $2.77
Upside: +117.00%
Nov 13, 2024
Reiterates: Buy
Price Target: $15
Current: $1.19
Upside: +1,165.82%
Oct 24, 2024
Maintains: Buy
Price Target: $25 → $35
Current: $4.12
Upside: +749.51%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $1.27
Upside: +529.92%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.17
Upside: +222.58%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.88
Upside: +45.35%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.35
Upside: +1,602.13%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.59
Upside: +25,323.73%
May 5, 2022
Downgrades: Neutral
Price Target: $10 → $3
Current: $0.45
Upside: +562.98%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $6.68
Upside: +124.55%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $2.18
Upside: +1,734.86%